Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2025-12-29 @ 2:14 AM
Study NCT ID:
NCT06070012
Status:
RECRUITING
Last Update Posted:
2025-12-15
First Post:
2023-09-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
Sponsor:
Diwakar Davar
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-18
Start Date Type:
ACTUAL
Primary Completion Date:
2028-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-20
First Submit QC Date:
None
Study First Post Date:
2023-10-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-08
Last Update Post Date:
2025-12-15
Last Update Post Date Type:
ESTIMATED